166 related articles for article (PubMed ID: 37699096)
1. Presence of T3SS (exoS, exoT, exoU and exoY), susceptibility pattern and MIC of MDR-Pseudomonas aeruginosa from burn wounds.
Ullah R; Amir M; Anjum S; Ur Rehman M; Noorul Hasan T; Sajjad Naqvi S; Faryal R; Ali Khan H; Khadija B; Arshad N; Rashid Z; Yousaf M; Ammad M; Mazhar K
J Infect Dev Ctries; 2023 Aug; 17(8):1130-1137. PubMed ID: 37699096
[TBL] [Abstract][Full Text] [Related]
2. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients.
Khodayary R; Nikokar I; Mobayen MR; Afrasiabi F; Araghian A; Elmi A; Moradzadeh M
BMC Res Notes; 2019 Jan; 12(1):28. PubMed ID: 30646938
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Shahri FN; Izanloo A; Goharrizi MASB; Jamali A; Bagheri H; Hjimohammadi A; Ardebili A
Int Microbiol; 2022 Nov; 25(4):709-721. PubMed ID: 35697891
[TBL] [Abstract][Full Text] [Related]
5. Characterization of clinical extensively drug resistant Pseudomonas aeruginosa from a Chinese teaching hospital.
Zou M; Wang H; Shui J; Li J; Hu Y; Dou Q; Yan Q; Liu WE
J Infect Dev Ctries; 2018 Oct; 12(10):835-841. PubMed ID: 32004151
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital.
Idris SN; Desa MN; Aziz MN; Taib NM
Southeast Asian J Trop Med Public Health; 2012 Jan; 43(1):116-23. PubMed ID: 23082561
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of
Liew SM; Rajasekaram G; Puthucheary SA; Chua KH
PeerJ; 2019; 7():e6217. PubMed ID: 30697478
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa serotypes and resistance to antibiotics from wound swabs.
Nedeljković NS; Tiodorović B; Kocić B; Cirić V; Milojković M; Waisi H
Vojnosanit Pregl; 2015 Nov; 72(11):996-1003. PubMed ID: 26731974
[TBL] [Abstract][Full Text] [Related]
10. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
Henderson A; Tan E; McCarthy KL; Paterson DL
Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
[TBL] [Abstract][Full Text] [Related]
11. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections.
Haghi F; Zeighami H; Monazami A; Toutouchi F; Nazaralian S; Naderi G
Microb Pathog; 2018 Feb; 115():251-256. PubMed ID: 29273509
[TBL] [Abstract][Full Text] [Related]
12.
Karlowsky JA; Lob SH; Siddiqui F; Akrich B; DeRyke CA; Young K; Motyl MR; Hawser SP; Sahm DF
J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36763081
[No Abstract] [Full Text] [Related]
13. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection.
Ghasemian S; Karami-Zarandi M; Heidari H; Khoshnood S; Kouhsari E; Ghafourian S; Maleki A; Kazemian H
J Clin Lab Anal; 2023 Apr; 37(4):e24850. PubMed ID: 36808649
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China.
Yu W; Zhang H; Zhu Y; Jia P; Xu Y; Yang Q
Int J Antimicrob Agents; 2023 Apr; 61(4):106741. PubMed ID: 36736928
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan.
Tarazi YH; Abu-Basha E; Ismail ZB; Al-Jawasreh SI
Acta Trop; 2021 May; 217():105859. PubMed ID: 33582141
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
Jarjees KK
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
[TBL] [Abstract][Full Text] [Related]
19. Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.
Hassuna NA
Surg Infect (Larchmt); 2016 Oct; 17(5):610-4. PubMed ID: 27441791
[TBL] [Abstract][Full Text] [Related]
20. Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran.
Azimi S; Kafil HS; Baghi HB; Shokrian S; Najaf K; Asgharzadeh M; Yousefi M; Shahrivar F; Aghazadeh M
GMS Hyg Infect Control; 2016; 11():Doc04. PubMed ID: 26958458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
